Aralez Pharma (ARLZ) Tops Q3 EPS by 5c; Boosts FY16 Revenue Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/30/2026

1. INTC
2. AMZN
3. RDDT
4. COIN
5. PINS
6. FSLR
7. SYK
8. DASH
9. GILD
10. SBUX

Go back to Aralez Pharma (ARLZ) Tops Q3 EPS by 5c; Boosts FY16 Revenue Outlook

Aralez Reports Third Quarter 2016 Financial Results

November 7, 2016 7:15 AM EST

-Completed Acquisitions of ZONTIVITY®; Toprol-XL® and its Authorized Generic-

-Received U.S. Food and Drug Administration Approval and Launched YOSPRALA-

-Provides Improved 2016 Full Year Guidance-

MISSISSAUGA, Ontario, Nov. 7, 2016 /PRNewswire/ -- Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ) (TSX: ARZ) ("Aralez" or the "Company") today announced financial results for the third quarter ended September 30, 2016. The Company also highlighted certain corporate and commercial updates. All figures are in U.S. dollars.

Corporate Updates:

On October... More